Literature DB >> 28990806

Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.

Ammar Majeed1,2,3, Maria Castedal4, Urban Arnelo1,5, Gunnar Söderdahl1,6, Annika Bergquist1, Karouk Said1.   

Abstract

BACKGROUND: Patients with primary sclerosing cholangitis (PSC) have increased risk of cholangiocarcinoma (CCA). We evaluated pre-transplant work-up in PSC patients, to search for the most effective strategy for the detection of biliary dysplasia or early CCA.
METHODS: Two hundred and twenty five consecutive PSC patients undergoing liver transplantation (LTx) in Sweden between 1999 and 2013 were studied. Patients with CCA or dysplasia in the explanted liver were compared with those with benign histopathology. Measures of test performance were calculated for patients having brush cytology on one endoscopic retrograde cholangiopancreaticography (ERCP) occasion, for those having repeated examinations with or without cholangioscopy, and for fluorescence in situ hybridization (FISH). Survival after LTx was analyzed.
RESULTS: Brush cytology on a single ERCP occasion had moderate sensitivity (57%) and high specificity (94%) for the detection of CCA/high grade dysplasia (HGD) in the explanted liver. The corresponding sensitivity and specificity for FISH were 84% and 90%, respectively. Utilizing repeated ERCP and brush cytology to confirm the initial finding improved sensitivity to 82%. Using single operator cholangioscopy (SOC) for targeted examination at the second ERCP improved sensitivity (100%) and specificity (97%) significantly. Mortality rate in patients with incidentally discovered CCA (n = 16) in the explanted liver was significantly higher than in patients with HGD or benign histopathology (HR 16.0; 95% CI, 5.6-45.4; p < .001).
CONCLUSIONS: Repeated brush cytology especially when combined with targeted examination under SOC guidance is superior to single brush examinations. This strategy improves the detection of malignancy in PSC and is of importance for selection of patients for LTx.

Entities:  

Keywords:  Cholangiocarcinoma; liver transplantation; sclerosing cholangitis

Mesh:

Year:  2017        PMID: 28990806     DOI: 10.1080/00365521.2017.1385840

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Concise Commentary: Why Cholangioscopy for Indeterminate Biliary Strictures in PSC Is Still Not Good Enough.

Authors:  Christoph Schramm
Journal:  Dig Dis Sci       Date:  2020-05       Impact factor: 3.199

2.  Cholangioscopy and its Role in Primary Sclerosing Cholangitis.

Authors:  Brian M Fung; M Phillip Fejleh; Sooraj Tejaswi; James H Tabibian
Journal:  Eur Med J Hepatol       Date:  2020-06-04

Review 3.  Role of Endoscopy in Primary Sclerosing Cholangitis.

Authors:  Purnima Bhat; Lars Aabakken
Journal:  Clin Endosc       Date:  2020-05-08

Review 4.  Choledochoscopy: An update.

Authors:  Tsinrong Lee; Thomas Zheng Jie Teng; Vishal G Shelat
Journal:  World J Gastrointest Endosc       Date:  2021-12-16

5.  Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.

Authors:  Hege Marie Vedeld; Marit M Grimsrud; Kim Andresen; Heidi D Pharo; Erik von Seth; Tom H Karlsen; Hilde Honne; Vemund Paulsen; Martti A Färkkilä; Annika Bergquist; Marine Jeanmougin; Lars Aabakken; Kirsten M Boberg; Trine Folseraas; Guro E Lind
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

6.  Refined pancreatobiliary UroVysion criteria and an approach for further optimization.

Authors:  Daniel Mettman; Azhar Saeed; Janna Shold; Raquele Laury; Andrew Ly; Irfan Khan; Shivani Golem; Mojtaba Olyaee; Maura O'Neil
Journal:  Cancer Med       Date:  2021-08-10       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.